Published in Proc Natl Acad Sci U S A on June 01, 1988
Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest (1996) 1.88
Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab (2009) 1.55
Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism. Endocrinol Metab Clin North Am (2009) 1.10
Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol (1991) 0.98
Anti-endothelial cell antibodies in insulin-dependent diabetes mellitus. Clin Exp Immunol (1992) 0.83
The immunofluorescence techniques in the diagnosis of endocrine autoimmune diseases. Auto Immun Highlights (2012) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy. J Clin Invest (1973) 4.57
Rapid isolation of plasma membranes in high yield from cultured fibroblasts. Biochem J (1977) 2.88
Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) (1981) 2.66
The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol (1966) 2.34
Autoimmune polyglandular syndromes. Pediatr Ann (1980) 2.00
Organ-specific autoimmunity: a 1986 overview. Immunol Rev (1986) 1.84
Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science (1983) 1.78
Antibody to the oxyphil cells of the human parathyroid in idiopathic hypoparathyroidism. Clin Exp Immunol (1969) 1.74
Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest (1984) 1.72
Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. Proc Natl Acad Sci U S A (1987) 1.48
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37
Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum (1972) 1.35
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27
Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. Proc Natl Acad Sci U S A (1986) 1.21
Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay. J Lab Clin Med (1987) 1.19
Human antibodies to vascular endothelium. Clin Exp Immunol (1971) 1.15
Endothelial cells from bovine adrenal medulla develop capillary-like growth patterns in culture. Proc Natl Acad Sci U S A (1985) 1.11
Bovine parathyroid cells: cultures maintained for more than 140 population doublings. Proc Natl Acad Sci U S A (1986) 1.04
Experimental investigations on immunology of the parathyroid gland. Immunology (1968) 0.98
Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions. Clin Exp Immunol (1985) 0.92
Functional epithelial cell line cloned from rat parathyroid glands. Proc Natl Acad Sci U S A (1987) 0.83
1,25-Dihydroxyvitamin D3 and phorbol esters (TPA) may induce select in vitro differentiation pathways in the HL60 promyelocytic cell line. Clin Immunol Immunopathol (1987) 0.82
Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro". J Biol Regul Homeost Agents (1988) 0.78
Cell surface marker studies in a patient with cutaneous multilobated T-cell lymphoma. Br J Dermatol (1985) 0.78
Idiopathic hypoparathyroidism and autoimmunity. Horm Res (1982) 0.78
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (1998) 11.90
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med (1999) 9.73
HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (1992) 8.68
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A (1994) 6.93
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science (1992) 5.99
Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation (1995) 5.90
DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev (1997) 5.76
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med (1994) 5.67
The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) (1981) 5.29
Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab (1971) 5.20
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int (2000) 4.85
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol (1995) 4.31
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13
Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol (1992) 3.68
Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol (1998) 3.67
Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J (1999) 3.46
Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone. J Clin Invest (1969) 3.41
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science (1992) 3.39
IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE. Proc Natl Acad Sci U S A (1963) 3.31
Isolation and characterization of linear deoxyribonucleic acid plasmids from Kluyveromyces lactis and the plasmid-associated killer character. J Bacteriol (1981) 3.30
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J Cell Biol (1998) 3.23
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19
Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell (1999) 3.16
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science (1994) 2.98
Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science (1968) 2.90
Parathyroid function and the renal excretion of 3'5'-adenylic acid. Proc Natl Acad Sci U S A (1967) 2.81
Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol (1995) 2.75
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood (2001) 2.65
Isolation and characterization of four plasmids from Bacillus subtilis. J Bacteriol (1977) 2.59
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A (2001) 2.57
Determination of 3',5'-adenosine monophosphate with a method based on a radioactive phosphate exchange reaction. J Biol Chem (1968) 2.47
Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A (1998) 2.39
Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology (1968) 2.36
Clonal rat parathyroid cell line expresses a parathyroid hormone-related peptide but not parathyroid hormone itself. Biochem Biophys Res Commun (1989) 2.15
Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med (1983) 2.14
Definition of specific peptide motifs for four major HLA-A alleles. J Immunol (1994) 2.11
The Stickler syndrome: evidence for close linkage to the structural gene for type II collagen. Genomics (1987) 2.11
A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways. EMBO J (1994) 2.09
Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab (1967) 2.00
Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci U S A (1994) 1.98
Curing of the killer deoxyribonucleic acid plasmids of Kluyveromyces lactis. J Bacteriol (1981) 1.97
Intergeneric transfer of deoxyribonucleic acid killer plasmids, pGKl1 and pGKl2, from Kluyveromyces lactis into Saccharomyces cerevisiae by cell fusion. J Bacteriol (1981) 1.97
Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet (1997) 1.90
Segmental spinal dysgenesis: neuroradiologic findings with clinical and embryologic correlation. AJNR Am J Neuroradiol (1999) 1.86
Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) (1992) 1.84
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res (1997) 1.82
A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res (1997) 1.82
Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology (2000) 1.80
Structures of mollusc shell framework proteins. Nature (1997) 1.80
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet (1997) 1.77
Noninvasive testing in the diagnosis of osteomalacia. Am J Med (1993) 1.76
Parathyroid hormone: chemical properties and structural requirements for biological and immunological activity. Recent Prog Horm Res (1966) 1.74
Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas. J Pathol (1998) 1.72
Evaluation by radioimmunoassay of factors controlling the secretion of parathyroid hormone. Nature (1966) 1.71
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70
Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med (1974) 1.69
A linear DNA plasmid from Streptomyces rochei with an inverted terminal repetition of 614 base pairs. EMBO J (1984) 1.69
The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene (2001) 1.69
Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site. Science (1974) 1.68
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett (1999) 1.68
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int (2010) 1.68
Analysis of linear plasmids isolated from Streptomyces: association of protein with the ends of the plasmid DNA. Plasmid (1982) 1.67
Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res (1990) 1.66
Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. Endocrinology (1969) 1.65
Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int (2003) 1.65
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med (1989) 1.64
High-resolution three-dimensional structure of a single zinc finger from a human enhancer binding protein in solution. Biochemistry (1990) 1.64
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science (1992) 1.63
Primary hyperparathyroidism: clinical and biochemical features. Medicine (Baltimore) (1974) 1.63
Bioassay of parathyroid hormone in vitro with a stable preparation of adenyl cyclase from rat kidney. Endocrinology (1969) 1.62
An efficient and cost-effective isotope labeling protocol for proteins expressed in Escherichia coli. J Biomol NMR (1998) 1.61
Transformation of Saccharomyces cerevisiae with linear DNA killer plasmids from Kluyveromyces lactis. J Bacteriol (1982) 1.61
Isolation of extrachromosomal deoxyribonucleic acids from extremely thermophilic bacteria. J Gen Microbiol (1978) 1.59
The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro. J Biol Chem (1970) 1.58
Control of tryptophan synthetase amplified by varying the numbers of composite plasmids in Escherichia coli cells. Gene (1977) 1.58
Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med (2005) 1.58
Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann Surg (1992) 1.57
Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab (2002) 1.57
Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med (1998) 1.57
Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science (1988) 1.56
Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab (1998) 1.56
Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology (2001) 1.56
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone (2011) 1.55
Mutations in the insulin receptor gene. Endocr Rev (1992) 1.55
dE2F2, a novel E2F-family transcription factor in Drosophila melanogaster. Biochem Biophys Res Commun (1998) 1.54
Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun (1980) 1.54
eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res (2000) 1.53
Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol (1997) 1.53